BB&T Corp lowered its stake in shares of Amdocs Limited (NASDAQ:DOX) by 15.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 39,987 shares of the technology company’s stock after selling 7,546 shares during the period. BB&T Corp’s holdings in Amdocs Limited were worth $2,577,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. FMR LLC boosted its stake in shares of Amdocs Limited by 12.8% in the first quarter. FMR LLC now owns 12,620,266 shares of the technology company’s stock valued at $769,710,000 after buying an additional 1,435,539 shares in the last quarter. BlackRock Inc. boosted its stake in shares of Amdocs Limited by 1,661.3% in the first quarter. BlackRock Inc. now owns 8,715,991 shares of the technology company’s stock valued at $531,590,000 after buying an additional 8,221,139 shares in the last quarter. Boston Partners boosted its stake in shares of Amdocs Limited by 9.7% in the first quarter. Boston Partners now owns 7,464,464 shares of the technology company’s stock valued at $455,257,000 after buying an additional 661,397 shares in the last quarter. Janus Capital Management LLC boosted its stake in shares of Amdocs Limited by 9.7% in the first quarter. Janus Capital Management LLC now owns 6,759,428 shares of the technology company’s stock valued at $412,250,000 after buying an additional 599,865 shares in the last quarter. Finally, OppenheimerFunds Inc. boosted its stake in shares of Amdocs Limited by 8.2% in the first quarter. OppenheimerFunds Inc. now owns 4,451,655 shares of the technology company’s stock valued at $271,507,000 after buying an additional 337,655 shares in the last quarter. 90.28% of the stock is owned by institutional investors and hedge funds.
Amdocs Limited (NASDAQ DOX) traded up 0.15% during mid-day trading on Friday, reaching $66.27. 477,868 shares of the company were exchanged. The company has a 50 day moving average of $65.23 and a 200-day moving average of $62.44. The company has a market capitalization of $9.67 billion, a price-to-earnings ratio of 23.03 and a beta of 0.54. Amdocs Limited has a 1-year low of $54.91 and a 1-year high of $67.62.
Amdocs Limited (NASDAQ:DOX) last posted its earnings results on Wednesday, August 2nd. The technology company reported $1.02 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.06. The company had revenue of $967 million for the quarter, compared to analyst estimates of $967.04 million. Amdocs Limited had a net margin of 11.11% and a return on equity of 14.83%. Amdocs Limited’s revenue was up 4.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.90 EPS. On average, equities research analysts forecast that Amdocs Limited will post $3.83 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 20th. Shareholders of record on Friday, September 29th will be issued a $0.22 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.88 annualized dividend and a yield of 1.33%. Amdocs Limited’s payout ratio is 30.66%.
ILLEGAL ACTIVITY WARNING: “Amdocs Limited (DOX) Shares Sold by BB&T Corp” was posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://stocknewstimes.com/2017/08/05/bbt-corp-has-2-58-million-position-in-amdocs-limited-dox-updated.html.
DOX has been the topic of several recent research reports. J P Morgan Chase & Co restated a “neutral” rating and set a $68.00 target price on shares of Amdocs Limited in a research report on Tuesday, May 9th. Stifel Nicolaus restated a “buy” rating and set a $72.00 target price (up from $68.00) on shares of Amdocs Limited in a research report on Thursday. Robert W. Baird upped their target price on shares of Amdocs Limited from $62.00 to $66.00 and gave the company a “neutral” rating in a research report on Wednesday, May 10th. Zacks Investment Research cut shares of Amdocs Limited from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $59.00 price objective on shares of Amdocs Limited in a research report on Friday, June 16th. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $67.63.
Amdocs Limited Company Profile
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Receive News & Ratings for Amdocs Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Limited and related companies with MarketBeat.com's FREE daily email newsletter.
